VIEWS: 14 PAGES: 4 CATEGORY: Health & Fitness POSTED ON: 11/24/2011
This report covers innovations across the percutaneous transluminal coronary angioplasty and transcatheter aortic valve spaces. Innovations in both devices and techniques are reviewed. Devices covered include drug eluting stents, drug coated balloons, embolic protection devices and trascatheter valves.
Innovations in Percutaneous Transluminal Coronary Angioplasty and Transcatheter Aortic Valves Published:November 2011 No.Of Pages:70 Price:US $ 3835 Report Summary This report covers innovations across the percutaneous transluminal coronary angioplasty and transcatheter aortic valve spaces. Innovations in both devices and techniques are reviewed. Devices covered include drug eluting stents, drug coated balloons, embolic protection devices and trascatheter valves. The report also examines the regulatory status of products under investigation. Features and benefits * Assess the markets for percutaneous transluminal coronary angioplasty devices and transcatheter valves. * Forecast epidemiology of key cardiology indications which impact the Percutaneous Transluminal Coronary Angioplasty and transcatheter aortic valve markets. * Evaluate innovations in percutaneous transluminal coronary angioplasty devices. * Analyze how percutaneous transluminal coronary angioplasty techniques are changing. * Gain an understanding of the leading transcatheter aortic valves which are under investigation for approval. Highlights The global market for percutaneous transluminal angioplasty is valued at $9.1bn in 2010, and is set to grow at a CAGR of 13.8% to reach $19.1bn in 2016. The market is being driven by the rise in procedural volumes with an increase in the average age of the population in the US and Japan, and the increase in the penetration of PCI in Asia. Future directions in the DES space focus on inventing DES that are safer (lower risk of thrombosis), more maneuverable in order to treat dispersed lesions, and have novel therapeutic properties, such as self-expandable DES, bifurcation stents and DES with more than one drug offering. New imaging techniques are the main area in transcatheter aortic valves innovation. Edwards Lifesciences Sapien valve became the first product to be approved in the US. Table Of Contents About the author Disclaimer EXECUTIVE SUMMARY Overview of percutaneous transluminal coronary angioplasty Innovations in PTCA products Innovations in PTCA techniques Innovations in transcatheter aortic valves Overview of percutaneous transluminal coronary angioplasty Summary Introduction Epidemiology of cardiovascular diseases Introduction to PTCA PTCA procedure Market size and forecasts for PTCA Historical market size and forecasts Innovations in PTCA products Summary Introduction Innovations Balloon catheters Drug-eluting stents Drug-eluting balloons Embolic protection devices Vascular access closure devices Innovations in PTCA techniques Summary Introduction Innovations Intravascular ultrasonography Coronary physiologic assessment Hybrid coronary intervention Adjunct PTCA therapies Anti-coagulants used in PTCA Innovations in transcatheter aortic valves Summary Introduction Etiology of valve disease Introduction to TAVI Implantation technique Market opportunities in TAVs Innovations in TAV Sapien valve CoreValve prosthesis Other investigational devices Leading trancatheter aortic valve manufacturers Appendix Scope Methodology Glossary/Abbreviations Bibliography/References List Of Tables Table: Epidemiology of major cardiovascular diseases, 2010 Table: Forecast epidemiology of dyslipidemia across the 7MM, 2010â€“16 Table: Forecast epidemiology of stroke across the 7MM, 2010â€“16 Table: Leading players in the global drug-coated balloon market Table: Developmental stages of selected drug-coated balloon devices Table: Standard derived IVUS measurements Table: Leading TAV manufacturers Table: Leading TAV manufacturers (contd.) List Of Figures Figure: Rotational atherectomy catheter Figure: Global Percutaneous Transluminal Coronary Angioplasty Market ($bn), 2010â€“16 Figure: Potential market size for various applications of DCBs in the US, 2012 Figure: Proximal occlusion device Figure: Fibernet device mounted on a guidewire Figure: Fibernet filter in the arterial vessel wall Figure: Vascular access closure device Figure: Normal coronary artery structure on IVUS Figure: Fractional flow reserve measurement using Intracoronary physiologic assessment Figure: Ishimaru classification of the thoracic aortic landing zones Figure: Normal aortic valve vs. bicuspid aortic valve Figure: Mechanical valve Figure: Tissue valve Figure: Transcatheter heart valve Figure: Transfemoral aortic valve implantation Figure: Transapical aortic valve implantation About Us: ReportsnReports is an online library of over 100,000+ market research reports and in-depth market research studies & analysis of over 5000 micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports. Follow us on Twitter: http://twitter.com/marketsreports Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689 Contact: Mr.Priyank 7557 Rambler road, Suite727,Dallas,TX75231 Tel: + 1 888 391 5441 E-mail: email@example.com http://www.reportsnreports.com Visit our Market Research Blog
Pages to are hidden for
"Innovations in Percutaneous Transluminal Coronary Angioplasty and Transcatheter Aortic Valves"Please download to view full document